Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2026-09-02 16:04:37 ET · period of report 2026-08-31 · accession 0000882796-26-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 16:04 | 2026-08-31 | BCRX | Frank Steven | Dir | A - Grant | $9.70 | +1,288 | 36.7K | +4% | +$12.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | A | A | 1,288 | $9.70 | 36,747 | D | — | — | (F1) Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $12,500. |